Literature DB >> 3292017

The toxic shock syndrome in a burn victim.

W C Egan1, W R Clark.   

Abstract

A case of toxic shock syndrome (TSS) in a 6-year-old boy with a 5 per cent body surface area partial thickness scald burn is reported. Biobrane was the wound dressing used initially. The clinical and laboratory characteristics of the syndrome are listed. The syndrome is caused by an exotoxin of Staph. aureus and can occur in the absence of invasive infection. The syndrome, first described in menstruating women who used tampons, has occurred in patients with a variety of wounds. Reports of the TSS syndrome in burn victims are limited to children whose wounds were covered. Children are most vulnerable to the development of TSS because of their limited prior exposure to the toxin.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3292017     DOI: 10.1016/0305-4179(88)90219-7

Source DB:  PubMed          Journal:  Burns Incl Therm Inj


  5 in total

Review 1.  Paediatric partial-thickness scald burns--is Biobrane the best treatment available?

Authors:  Anirban Mandal
Journal:  Int Wound J       Date:  2007-03       Impact factor: 3.315

2.  Scalds among children in Kuwait.

Authors:  R L Bang; M K Ebrahim; P N Sharma
Journal:  Eur J Epidemiol       Date:  1997-01       Impact factor: 8.082

Review 3.  Current wound healing procedures and potential care.

Authors:  Michael B Dreifke; Amil A Jayasuriya; Ambalangodage C Jayasuriya
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2014-12-19       Impact factor: 7.328

4.  Integra dermal regeneration template as the nidus of staphylococcal toxic shock syndrome: A case report.

Authors:  Santiago R Gonzalez; James C Yuen
Journal:  JPRAS Open       Date:  2020-05-29

Review 5.  Made in Germany: A Quality Indicator Not Only in the Automobile Industry But Also When It Comes to Skin Replacement: How an Automobile Textile Research Institute Developed a New Skin Substitute.

Authors:  Herbert Leopold Haller; Matthias Rapp; Daniel Popp; Sebastian Philipp Nischwitz; Lars Peter Kamolz
Journal:  Medicina (Kaunas)       Date:  2021-02-05       Impact factor: 2.430

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.